Codexis, a biocatalyst research company, signs "multimillion" dollar deal with Merck

April 4, 2007 | Editor
View Comments

Codexis, a biocatalyst research company based in Redwood City, Ca., has signed a significant licensing deal with Merck & Co.

See the statement here. The terms weren’t disclosed, but the company tells VentureWire it is in the multimillions of dollars (sub required).

Next Story:
Previous Story:

Print
Email
Twitter
Facebook
Google Buzz
LinkedIn
Digg
StumbleUpon
Reddit
Delicious
Google
More...
blog comments powered by Disqus